CAS 6402-23-9 API Powder Ethacridine Lactate Monohydrate Solution Rivanol

Product Description

API Powder Ethacridine Lactate Monohydrate Solution Rivanol CAS 6402-23-9

Product Indications of Ethacridine Lactate Monohydrate
1. It can be used to induce labour in mid-term pregnancy, with a success rate of over 95%. The effect is still satisfactory as there are no other uncomfortable symptoms except painful contractions, and the fetus is expelled quickly.

2. This product is an antiseptic and antiseptic agent for external use. It has a strong killing effect on Gram-positive bacteria and a few Gram-negative bacteria, and a stronger antibacterial effect on cocci, especially streptococci. It is used for all kinds of wounds, exuding and erosive infectious skin diseases and wound irrigation. The product is less irritating and the general therapeutic concentration is not harmful to the tissue. Topical concentration 0.1%-0.2%.

Product Function of Ethacridine Lactate Monohydrate
1. Disinfection: Ethacridine Lactate Monohydrate is a disinfectant and antiseptic that inhibits the growth of Gram-positive bacteria, especially cocci. The solution can be used for the disinfection of small, lightly traumatised wounds and infected wounds. It can cause burning sensation, allergy, rash, itching and other adverse reactions.

2. Bactericidal: Ethacridine Lactate Monohydrate is disinfectant and bactericidal and can be used externally as a cream to disinfect small wounds on the skin surface. Occasionally there are allergic reactions.

3. Induction of labour in mid pregnancy: Ethacridine Lactate Monohydrate Injection is commonly used to induce labour in mid pregnancy by injecting a concentration into the amniotic cavity to cause sterile inflammation, stimulate uterine contractions and expel the foetus.

Certificate of Analysis

Cautions of Ethacridine Lactate Monohydrate
1. The dose of this product should be controlled when used to induce labour. An overdose (e.g. more than 1 g) may cause renal impairment or even death.
2. The main complication is high bleeding. In order to reduce bleeding, it is generally appropriate to use it for induction of labour at 16-24 weeks of gestation.

3. The provisional period of use of the injection is 3 to 6 months. Ethacridine Lactate Monohydrate for injection should be prepared temporarily before injection, dissolved in water for injection, not in isotonic saline as a solvent, and not in combination with solutions containing chloride or alkaline solutions to avoid precipitation.
4. Forbidden for patients with heart, liver and kidney diseases.
5. The product should not be used to flush the cavity for renal dysfunction and haematuria.
6. This product should not be dissolved in saline. This product is prone to precipitation when mixed with alkaline and sulphur solutions and has been reported to cause allergic reactions.